Latest
Why waiving intellectual property rights for Covid vaccines is wrong
The UK, EU and other allies should speak out against the badly thought out proposal before the WTO.
Why intellectual property rights matter for COVID-19
The IP system has been crucial in underpinning the research, development and manufacture of vaccines and therapeutics for COVID-19, proving critics of IP wrong at every step of this crisis.
Featured
A statement of principles on medicines procurement
This is a statement of principles on medicines procurement collectively issued by think tanks from Argentina, Brazil, Chile, Colombia and Mexico.
Why intellectual property rights matter for COVID-19
The IP system has been crucial in underpinning the research, development and manufacture of vaccines and therapeutics for COVID-19, proving critics of IP wrong at every step of this crisis.
Overcoming obstacles to medicines access
As the 2020 World Health Assembly re-convenes in Geneva, an international coalition of think tanks urges governments to commit to simple reforms to accelerate access to medicines, including those in the process of being developed for Covid-19.
Priorities for UK trade liberalisation
As the UK develops its trade policy outside of the EU, it would be a mistake to base its future approach on the one it inherits from the EU.
Watch: How intellectual property rights are helping to beat Covid-19
Experts from the life science and research community explain the crucial role of intellectual property rights in developing new vaccines and therapeutics for Covid-19.
Una declaración de principios sobre la compra de medicamentos
La siguiente es una declaración de principios sobre la compra de medicamentos emitida en conjunto por centros de estudios de Argentina, Brasil, Chile, Colombia y México.
